Clinical Trials Directory

Trials / Completed

CompletedNCT01675804

Computer-assisted Cognitive Rehabilitation (CACR), Placebo CACR and Psycho-stimulants in the Treatment of ADHD

A Randomized Clinical Trial Comparing Computer-assisted Cognitive Rehabilitation (CACR), Psycho-stimulants, and Placebo CACR in the Treatment of Attention Deficit/ Hyperactivity Disorder

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
34 (actual)
Sponsor
Allameh Tabatabai University · Academic / Other
Sex
Male
Age
7 Years – 12 Years
Healthy volunteers
Not accepted

Summary

Current research aimed to compare the efficacy of computer-assisted cognitive rehabilitation (CACR), stimulant drugs and Placebo CACR on executive functions and clinical symptoms of children with attention deficit/hyperactivity disorder (ADHD).

Detailed description

The investigators administered a randomized controlled trial (RCT) through random assignment of ADHD subjects in to three different groups to compare the effects of CACR, immediate-release methylphenidate, and a Placebo CACR (i.e. some computerized tasks assumed not having any therapeutic effects) on the functioning of children with ADHD.

Conditions

Interventions

TypeNameDescription
OTHERComputerized cognitive rehabilitation\- Computerized cognitive rehabilitation: 20 ninety-minute sessions of computerized cognitive rehabilitation.
DRUGRitalin-drug therapy: 2 or 3 doses of 10 mg tablets of Immediate-release Methylphenidate (Ritalin) per day for 2 months.
OTHERPlacebo CACR [PCACR]PCACR: 20 ninety-minute sessions of Placebo computerized cognitive training.

Timeline

Start date
2011-11-01
Primary completion
2012-04-01
Completion
2012-05-01
First posted
2012-08-30
Last updated
2015-04-06

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT01675804. Inclusion in this directory is not an endorsement.